ClinicalTrials.govpublic full text
High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide
lupus erythematosus, systemic, systemic lupus erythematosus (sle), cytoxan, cyclophosphamide, high-dose immunoablative therapy, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 860755
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.